产品名称 | NebuSelect™ Recombinant Human CD46, His-tag |
---|---|
目录号 | NBL-242908 |
别名 | CD46; TLX; CD46; MCP; MIC10; AHUS2; TRA2.10 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P15529-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242908-100ug | 100ug | Inquire | Inquire | |
NBL-242908-1mg | 1mg | Inquire | Inquire | |
NBL-242908-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CD46, His-tag
Catalog#:
NBL-242908
Description:
NebuSelect™ Recombinant Human CD46, His-tag(Cat#NBL-242908) is expressed in HEK293 with His tag at the C-Terminus.It contains Cys35-Asp343.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 35.4 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
CD46; TLX; CD46; MCP; MIC10; AHUS2; TRA2.10
Target Information:
CD46 was discovered in 1986 during a search for novel C3b-binding proteins. CD46 is expressed ubiquitously and functions as a co-factor in the factor I-mediated proteolytic cleavage of C3b and C4b. Its vital role in preventing complement deposition on host tissue is underpinned by the fact that deficiency of CD46 is a predisposing factor for numerous disease conditions arising from complement-mediated 'self-attack'.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.